We are live on
!
Find out more
CANY
Caxton Associates (New York) Portfolio holdings
AUM
$3.18B
1-Year Est. Return
54.49%
This Fund
S&P 500
This Quarter
Est. Return
+7.67%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$2.8B
AUM Growth
+$207M
(+8%)
Cap. Flow
+$89.9M
Cap. Flow
% of AUM
3.21%
Top 10 Holdings %
Top 10 Hldgs %
37.33%
Holding
678
New
219
Increased
84
Reduced
142
Closed
204
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$101M |
| 2 |
Chevron
CVX
|
+$95.5M |
| 3 |
Bank of America
BAC
|
+$45.5M |
| 4 |
Kinder Morgan
KMI
|
+$25.5M |
| 5 |
Sociedad Química y Minera de Chile
SQM
|
+$20.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$45.5M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$26.6M |
| 3 |
ATH
Athene Holding Ltd. Class A Common Shares
ATH
|
+$24.6M |
| 4 |
Parker-Hannifin
PH
|
+$17.3M |
| 5 |
Vulcan Materials
VMC
|
+$13.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 17.33% |
| 2 | Financials | 7.75% |
| 3 | Consumer Discretionary | 6.84% |
| 4 | Industrials | 6% |
| 5 | Materials | 5.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Idexx Laboratories
IDXX
$46.5B
| $264K | 0.01% |
1,700
-900
| -35% | -$142K |
|
|
STMP
452
DELISTED
Stamps.com, Inc.
STMP
| $263K | 0.01% |
+1,300
| New | +$238K |
|
453
Regions Financial
RF
$26.8B
| $259K | 0.01% |
+17,000
| New | +$244K |
|
454
Incyte
INCY
$24B
| $257K | 0.01% |
+2,200
| New | +$278K |
|
|
MOMO
455
Hello Group
MOMO
$855M
| $254K | 0.01% |
+8,100
| New | +$322K |
|
456
Entergy
ETR
$49.7B
| $252K | 0.01% |
+6,600
| New | +$255K |
|
|
KEM
457
DELISTED
KEMET Corporation
KEM
| $251K | 0.01% |
+11,900
| New | +$225K |
|
458
Zoetis
ZTS
$32.4B
| $249K | 0.01% |
+3,900
| New | +$244K |
|
459
Akebia Therapeutics
AKBA
$264M
| $246K | 0.01% |
+12,500
| New | +$192K |
|
460
LyondellBasell Industries
LYB
$19.8B
| $238K | 0.01% |
2,400
-4,100
| -63% | -$369K |
|
461
Teva Pharmaceuticals
TEVA
$40.6B
| $234K | 0.01% |
13,300
+300
| +2% | +$6.75K |
|
462
Eaton
ETN
$174B
| $230K | 0.01% |
3,000
-47,000
| -94% | -$3.55M |
|
|
MTGE
463
DELISTED
MTGE Investment Corp. Common Stock
MTGE
| $230K | 0.01% |
11,848
-17,868
| -60% | -$341K |
|
|
INFO
464
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $229K | 0.01% |
+5,200
| New | +$240K |
|
465
Agilent Technologies
A
$39.9B
| $225K | 0.01% |
+3,500
| New | +$218K |
|
466
AerCap
AER
$24.4B
| $225K | 0.01% |
+4,400
| New | +$216K |
|
|
XYZ
467
Block Inc
XYZ
$47.5B
| $222K | 0.01% |
7,700
-8,400
| -52% | -$220K |
|
468
NetEase
NTES
$83.5B
| $211K | 0.01% |
4,000
-3,000
| -43% | -$172K |
|
|
ESRX
469
DELISTED
Express Scripts Holding Company
ESRX
| $209K | 0.01% |
+3,300
| New | +$205K |
|
470
Cognizant
CTSH
$25.6B
| $203K | 0.01% |
+2,800
| New | +$197K |
|
|
CYOU
471
DELISTED
Changyou.com Limited American Depositary Share
CYOU
| $202K | 0.01% |
+5,100
| New | +$205K |
|
472
Corcept Therapeutics
CORT
$11.7B
| $199K | 0.01% |
+10,300
| New | +$154K |
|
473
FerroAtlántica
GSM
$772M
| $151K | 0.01% |
+11,500
| New | +$149K |
|
474
ICICI Bank
IBN
$109B
| $91K | ﹤0.01% |
+10,600
| New | +$96.9K |
|
475
PUT
Apple
AAPL
$4.56T
| – | – |
-80,000
| Closed | -$2.88M |
|
Similar funds
BFM
MWM
CCM
ECG
LSAG
KL
WP
RDIA
Caxton Associates (New York)'s Q3 2017 Portfolio in Review
As of Q3 2017, Caxton Associates (New York) held 678 positions worth $2.8B, up 8% from $2.59B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Caxton Associates (New York) deployed $89.9M of net new capital in Q3 2017, opening 219 new positions and adding to 84 existing holdings. Its largest new stake was Chevron: 874,800 shares worth $103M.
By sector, the portfolio is most concentrated in Energy at 17% of assets, up from 14% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was ExxonMobil, an estimated $45.5M trimmed.
- Caxton Associates (New York)'s largest Q3 2017 buy was Chevron: 874,800 shares worth $103M.
- Caxton Associates (New York) added most to JPMorgan Chase in Q3 2017, an estimated $101M increase.
- Caxton Associates (New York)'s biggest Q3 2017 reduction was ExxonMobil, cutting an estimated $45.5M.
- Caxton Associates (New York) fully exited Parker-Hannifin in Q3 2017, selling an estimated $17.3M.
- Caxton Associates (New York)'s ten largest holdings make up 37% of its $2.8B portfolio in Q3 2017.
- Caxton Associates (New York) opened 219 new positions and closed 204 in Q3 2017.
- Caxton Associates (New York)'s portfolio value rose 8% quarter-over-quarter to $2.8B.
Based on Caxton Associates (New York)'s 13F filing for Q3 2017, filed 14 Nov 2017.